Profile data is unavailable for this security.
About the company
Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.
- Revenue in HKD (TTM)52.65m
- Net income in HKD-337.89m
- Incorporated1998
- Employees161.00
- LocationExtrawell Pharmaceutical Holdings LtdSuites 2206-08, 22nd Floor, Devon House,Taikoo Place, 979 King's Road,Quarry Bay Hong KongHKG
- Phone+852 28561918
- Fax+852 28563139
- Websitehttp://www.extrawell.com.hk
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanai Health Industry Group Co Ltd | 108.24m | -37.60m | 64.98m | 147.00 | -- | 0.1878 | -- | 0.6003 | -0.2458 | -0.1179 | 0.7076 | 2.26 | 0.1994 | 8.97 | 9.71 | 660,020.40 | -7.70 | 3.50 | -10.97 | 5.00 | 17.61 | 37.40 | -38.60 | 10.86 | 2.58 | -6.86 | 0.1487 | 0.00 | -20.92 | 0.8085 | -176.60 | -- | -9.02 | -- |
| Kontafarma China Holdings Ltd | 891.73m | -362.77m | 178.83m | 655.00 | -- | 0.2611 | -- | 0.2006 | -0.065 | -0.065 | 0.1598 | 0.1226 | 0.6269 | 4.43 | 7.06 | 1,296,115.00 | -29.24 | -2.95 | -39.76 | -4.38 | 55.36 | 55.42 | -46.64 | -7.85 | 0.8036 | -- | 0.2753 | -- | 10.93 | -0.5183 | -161.89 | -- | -31.47 | -- |
| PuraPharm Corp Ltd | 346.76m | -38.56m | 179.53m | 469.00 | -- | 1.30 | 12.31 | 0.5177 | -0.0976 | -0.0976 | 0.8778 | 0.2568 | 0.4749 | 1.39 | 6.98 | 723,920.70 | -5.28 | -6.50 | -15.35 | -14.97 | 53.93 | 59.22 | -11.12 | -14.08 | 0.3313 | -1.14 | 0.7865 | -- | -6.09 | -11.30 | 66.59 | -- | -29.92 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 52.65m | -337.89m | 209.10m | 161.00 | -- | 0.2343 | -- | 3.97 | -0.1351 | -0.1352 | 0.0219 | 0.3501 | 0.0422 | 10.54 | 5.89 | 322,975.50 | -27.00 | 3.07 | -28.13 | 3.21 | 42.41 | 47.65 | -640.53 | 59.77 | 13.00 | -0.037 | 0.146 | -- | -6.21 | -6.50 | 236.70 | 21.75 | 80.07 | -- |
| Tianda Pharmaceuticals Ltd | 310.50m | -67.37m | 232.20m | 624.00 | -- | 0.4779 | -- | 0.7478 | -0.0313 | -0.0313 | 0.1444 | 0.226 | 0.3931 | 2.84 | 5.14 | 442,937.20 | -8.57 | -- | -12.38 | -- | 42.76 | -- | -21.80 | -- | 0.6900 | -15.81 | 0.2183 | -- | -37.99 | -- | -154.07 | -- | -- | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.12bn | 6.98m | 270.16m | 1.47k | 38.68 | 0.3378 | 6.44 | 0.2405 | 0.0042 | 0.0042 | 0.6694 | 0.4767 | 0.783 | 3.68 | 5.65 | 756,339.00 | -0.4295 | 2.52 | -0.6329 | 3.76 | 29.12 | 43.41 | -0.5486 | 3.33 | 1.48 | 2.03 | 0.1157 | 139.17 | -2.18 | -0.7356 | 3.68 | -15.97 | -7.87 | -- |
| Regent Pacific Group Ltd | 7.15m | -31.86m | 294.73m | 17.00 | -- | -- | -- | 41.20 | -0.1388 | -0.1388 | 0.0312 | -0.1117 | 1.20 | -- | 6.96 | 420,776.20 | -535.26 | -47.86 | -- | -61.88 | -- | -- | -445.46 | -1,658.64 | -- | -11.90 | -- | -- | 153.63 | 2.17 | 82.11 | -- | -5.59 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 95.53m | -40.10m | 311.16m | 185.00 | -- | 2.19 | -- | 3.26 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| Wai Yuen Tong Medicine Holdings Ltd | 721.27m | -13.83m | 399.41m | 726.00 | -- | 0.3376 | 5.40 | 0.5538 | -0.0123 | -0.0123 | 0.6411 | 1.05 | 0.4165 | 1.41 | 9.68 | 950,292.50 | -0.7998 | -1.81 | -1.06 | -3.10 | 49.87 | 44.67 | -1.92 | -11.19 | 0.7806 | -- | 0.2033 | -- | -4.92 | 3.73 | 126.62 | -56.16 | 31.89 | -- |
| China NT Pharma Group Co Ltd | 21.10m | -80.21m | 505.68m | 21.00 | -- | -- | -- | 23.96 | -0.2327 | -0.2327 | 0.0487 | -0.4644 | 0.0546 | -- | 3.09 | 959,149.40 | -20.76 | -10.31 | -- | -- | 51.27 | -- | -380.13 | -97.11 | 0.0447 | -0.3973 | 7.95 | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.27bn | 23.25m | 639.06m | 2.49k | 26.86 | 0.5204 | 4.44 | 0.2816 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 880,727.40 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Fusen Pharmaceutical Co Ltd | 272.55m | -197.89m | 657.98m | 1.05k | -- | 1.68 | -- | 2.41 | -0.2677 | -0.2677 | 0.3687 | 0.5301 | 0.1875 | 1.11 | 4.05 | 240,982.60 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 680.72m | 504.00 | 7.48 | 1.78 | 5.95 | 1.15 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
Data as of Feb 13 2026. Currency figures normalised to Extrawell Pharmaceutical Holdings Ltd's reporting currency: Hong Kong Dollar HKD
